Balchem Co. (NASDAQ:BCPC) Shares Purchased by Grantham Mayo Van Otterloo & Co. LLC

Grantham Mayo Van Otterloo & Co. LLC lifted its holdings in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 4.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 204,212 shares of the basic materials company's stock after purchasing an additional 7,855 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC owned about 0.63% of Balchem worth $33,286,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Balchem by 6.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 83,651 shares of the basic materials company's stock worth $14,723,000 after buying an additional 4,812 shares during the last quarter. Benjamin Edwards Inc. boosted its position in shares of Balchem by 18.6% in the third quarter. Benjamin Edwards Inc. now owns 2,647 shares of the basic materials company's stock worth $466,000 after acquiring an additional 416 shares during the last quarter. HighTower Advisors LLC grew its holdings in Balchem by 15.3% in the third quarter. HighTower Advisors LLC now owns 2,229 shares of the basic materials company's stock valued at $391,000 after purchasing an additional 295 shares during the period. Stifel Financial Corp increased its position in Balchem by 26.2% during the third quarter. Stifel Financial Corp now owns 11,893 shares of the basic materials company's stock worth $2,093,000 after purchasing an additional 2,467 shares during the last quarter. Finally, State Street Corp raised its stake in Balchem by 1.0% during the third quarter. State Street Corp now owns 1,234,226 shares of the basic materials company's stock worth $217,224,000 after purchasing an additional 12,006 shares during the period. Hedge funds and other institutional investors own 87.91% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on BCPC shares. Sidoti raised shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th. StockNews.com downgraded Balchem from a "buy" rating to a "hold" rating in a research report on Tuesday, February 25th. Finally, HC Wainwright restated a "buy" rating and issued a $190.00 price objective on shares of Balchem in a report on Monday, February 24th.

Balchem Trading Up 2.4 %

Shares of Balchem stock traded up $3.75 during trading hours on Friday, hitting $159.84. The company's stock had a trading volume of 52,575 shares, compared to its average volume of 126,944. The business has a fifty day moving average of $164.84 and a 200 day moving average of $168.19. Balchem Co. has a 1-year low of $137.69 and a 1-year high of $186.03. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The company has a market capitalization of $5.20 billion, a PE ratio of 5.66, a P/E/G ratio of 4.41 and a beta of 0.75.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.11 by ($0.08). The company had revenue of $240.00 million during the quarter, compared to analyst estimates of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. As a group, equities analysts forecast that Balchem Co. will post 4.64 EPS for the current year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.